Literature DB >> 32572851

Editorial Comment on: DPP9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer.

Takehiko Yokobori1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32572851     DOI： 10.1245/s10434-020-08746-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  15 in total

Review 1.  Progress and future direction in the management of advanced colorectal cancer.

Authors:  K G M Brown; M J Solomon
Journal:  Br J Surg       Date:  2018-05       Impact factor: 6.939

Review 2.  Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis.

Authors:  Shahzad M Ali; Timothy M Pawlik; Miguel A Rodriguez-Bigas; John R T Monson; George J Chang; David W Larson
Journal:  Ann Surg Oncol       Date:  2017-02-21       Impact factor: 5.344

3.  Differential expression of inflammasomes in lung cancer cell lines and tissues.

Authors:  Hui Kong; Yanli Wang; Xiaoning Zeng; Zailiang Wang; Hong Wang; Weiping Xie
Journal:  Tumour Biol       Date:  2015-04-25

Review 4.  Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients.

Authors:  Rodrigo Dienstmann; Ramon Salazar; Josep Tabernero
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

5.  Neoadjuvant radiation for clinical T4 colon cancer: A potential improvement to overall survival.

Authors:  Alexander T Hawkins; Molly M Ford; Timothy M Geiger; M Benjamin Hopkins; Lisa A Kachnic; Roberta L Muldoon; Sean C Glasgow
Journal:  Surgery       Date:  2018-07-14       Impact factor: 3.982

Review 6.  Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.

Authors:  L Wagner; C Klemann; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-03-02       Impact factor: 4.330

Review 7.  Comparing SGLT-2 inhibitors to DPP-4 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  B M Mishriky; R J Tanenberg; K A Sewell; D M Cummings
Journal:  Diabetes Metab       Date:  2018-02-07       Impact factor: 6.041

Review 8.  Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy.

Authors:  Dev Karan
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

Review 9.  KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy.

Authors:  Ahmad D Siddiqui; Bilal Piperdi
Journal:  Ann Surg Oncol       Date:  2009-11-20       Impact factor: 5.344

10.  Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding.

Authors:  Franklin L Zhong; Kim Robinson; Daniel Eng Thiam Teo; Kiat-Yi Tan; Chrissie Lim; Cassandra R Harapas; Chien-Hsiung Yu; William H Xie; Radoslaw M Sobota; Veonice Bijin Au; Richard Hopkins; Andrea D'Osualdo; John C Reed; John E Connolly; Seth L Masters; Bruno Reversade
Journal:  J Biol Chem       Date:  2018-10-05       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.